Polycystic ovary syndrome (PCOS)-like phenotypes in the d-galactose-induced aging mouse model.

Abstract The d -galactose ( d -gal)-induced animal model, which is established by consecutive subcutaneous d -gal injections for approximately 6 weeks, has been frequently used for aging research. This animal model has been shown to accelerate aging of the brain, kidneys, liver, and blood cells. However, aging of the female reproductive organs in this animal model has not been reported. The aim of this study was to investigate changes in the ovary in the d -gal-induced aging mouse model. First, we evaluated anti-Mullerian hormone (AMH) as a marker of ovarian aging in blood plasma. We speculated there would be lower AMH levels in d -gal-treated mice because ovarian aging would be induced by d -gal, as reported for other tissues. However, the results showed that AMH levels in d -gal-treated mice were approximately four-fold higher than control mice. Abnormally high AMH levels are detected in ovarian cancer and polycystic ovary syndrome (PCOS) patients. Therefore, we examined PCOS-related markers in this mouse model. Total testosterone levels were high and abnormal estrous cycles were induced in d -gal-treated mice. These changes, including AMH levels, in d -gal-treated mice were inhibited by aminoguanidine treatment, an advanced glycation end product reducer. In addition, ovarian cysts were observed in some d -gal-treated mice. These results indicate that with respect to female reproduction, d -gal-treated mice are suitable for PCOS studies, rather than aging studies.